Herceptin and breast cancer: An overview for surgeons
Author:
Publisher
Elsevier BV
Subject
Oncology,Surgery
Reference100 articles.
1. The HER receptor family: a rich target for therapeutic development;Mass;Int J Radiat Oncol Biol Phys,2004
2. The molecular and cellular biology of HER2/neu gene amplification/overexpression and the clinical development of herceptin (trastuzumab) therapy for breast cancer;Pegram;Cancer Treat Res,2000
3. Biological rationale for HER2/neu (cerbB2) as a target for mono clonal antibody therapy;Pegram;Semin Oncol,2000
4. Human breast cancer: correlation of relapse and survival with amplification of the HER-2/neu oncogene;Slamon;Science,1987
5. Biology of HER2 and its importance in breast cancer;Yarden;Oncology,2001
Cited by 12 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Intense basolateral membrane staining indicates HER2 positivity in invasive micropapillary breast carcinoma;Modern Pathology;2020-01-23
2. State of the art in anti-cancer mAbs;Journal of Biomedical Science;2017-02-20
3. Trastuzumab in the Treatment of Breast Cancer;BioDrugs;2016-02-18
4. Comparison of three different conjugation strategies in the construction of herceptin-bearing paclitaxel-loaded nanoparticles;Biomaterials Science;2016
5. Effect and safety of dual anti-human epidermal growth factor receptor 2 therapy compared to monotherapy in patients with human epidermal growth factor receptor 2-positive breast cancer: a systematic review;BMC Cancer;2014-08-28
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3